The Natural History of Cerebral Cavernous Malformations in Children
Overview
Pediatrics
Affiliations
OBJECT Cerebral cavernous malformations (CMs) are a source of neurological morbidity from seizures and focal neurological deficits due to mass effect and hemorrhage. Although several natural history reports exist for adults with CMs, similar data for pediatric patients are limited. METHODS The authors reviewed hospital databases to identify children with CMs who had not been treated surgically and who had clinical and radiological follow-up. Annual hemorrhage rates were calculated in lesion-years, and risk factors were assessed using the Cox proportional hazards model. RESULTS In a cohort of 167 patients with 222 CMs, the mean patient age at the time of diagnosis was 10.1 years old (SD 6.0). Ninety patients (54%) were male. One hundred four patients (62%) presented with hemorrhage from at least 1 CM, 58 (35%) with seizures with or without CM hemorrhage, and 43 (26%) with incidental lesions. Twenty-five patients (15%) had multiple CMs, 17 (10%) had a family history of CMs, and 33 (20%) had radiologically apparent developmental venous anomalies (DVAs). The overall annual hemorrhage rate was 3.3%. Permanent neurological morbidity was 29% per hemorrhage, increasing to 45% for brainstem, thalamic, or basal ganglia CM and decreasing to 15% for supratentorial lobar or cerebellar lesions. The annual hemorrhage rate for incidental CMs was 0.5%; for hemorrhagic CMs, it was 11.3%, increasing to 18.2% within the first 3 years. Hemorrhage clustering within 3 years was statistically significant (HR 6.1, 95% CI 1.72-21.7, p = 0.005). On multivariate analysis, hemorrhagic presentation (HR 4.63, 95% CI 1.53-14.1, p = 0.007), brainstem location (HR 4.42, 95% CI 1.57-12.4, p = 0.005), and an associated radiologically apparent DVA (HR 2.91, 95% CI 1.04-8.09, p = 0.04) emerged as significant risk factors for hemorrhage, whereas age, sex, CM multiplicity, and CM family history did not. CONCLUSIONS Prior hemorrhage, brainstem location, and associated DVAs are significant risk factors for symptomatic hemorrhage in children with CMs. Hemorrhage clustering within the first 3 years of a bleed can occur, a potentially important factor in patient management and counseling.
Improving methodology of radiosurgery for posterior fossa cavernomas: higher volume, lower dose.
Nataf F, Scher N, Bollet M, Mulier G, Birladeanu A, Sopanda L Acta Neurochir (Wien). 2025; 167(1):29.
PMID: 39891775 PMC: 11787227. DOI: 10.1007/s00701-024-06409-z.
Outcomes after surgical and nonsurgical treatment of pediatric cerebral cavernous malformation.
Zhang H, Yu Q, Mao Z, Zhang L, Yu X Pediatr Investig. 2024; 8(2):126-134.
PMID: 38910851 PMC: 11193375. DOI: 10.1002/ped4.12435.
Li X, Jones P, Zhao M Sci Rep. 2024; 14(1):11022.
PMID: 38745042 PMC: 11094099. DOI: 10.1038/s41598-024-61851-4.
Brainstem cavernous hemangioma with improvement of Holmes tremor on excision.
Eguchi H, Aihara Y, Chiba K, Oda Y, Momozaki O, Saitou R Childs Nerv Syst. 2024; 40(8):2615-2618.
PMID: 38639803 DOI: 10.1007/s00381-024-06423-7.
Clinical Features and Treatment of Pediatric Cerebral Cavernous Malformations.
Phi J, Kim S J Korean Neurosurg Soc. 2024; 67(3):299-307.
PMID: 38547881 PMC: 11079565. DOI: 10.3340/jkns.2024.0047.